@NuclearYoshi @vonbateman Scepticism leads to septic choc :A double blind randomized placebo-controlled study to assess the stupidness of the patients New English journal of Moron
A double-blind, randomized, placebo-controlled study to assess the efficacy of Andrographis paniculata standardized extract (ParActin®) on pain reduction in subjects with knee osteoarthritis.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Apr 2019 – May 2025Where it's discussed
-
X / Twitter18 posts
-
Facebook6 posts
-
News3 articles
-
Bluesky2 posts
-
YouTube2 videos
AI synopsis
What people are saying
The discussions reflect a mix of cautious support and skepticism, with some posts calling the research 'effective against osteoarthritis' and others making dismissive or humorous remarks like 'stupidness of the patients,' which dilute the overall perceived seriousness. The tone varies from clinical acknowledgment to sarcasm, influencing the overall neutral score across the dimensions.
Most discussions acknowledge the study's findings but are mixed in enthusiasm, with some skepticism and some support for the reported benefits.
The discussions show moderate interest, especially among those in healthcare or research, but also include dismissive remarks and unrelated comments.
Participants mostly mention the study briefly or in passing, with few in-depth analyses or detailed discussions, indicating moderate engagement.
The conversation seems to recognize the study's relevance but does not reflect a widespread perception of profound impact, more like cautious interest.
Abstract in brief
- This study tested the effectiveness of ParActin, a supplement made from Andrographis paniculata, in reducing knee pain associated with osteoarthritis, using a double-blind placebo-controlled design.
- Results showed that patients taking either 300mg or 600mg of ParActin daily experienced significant decreases in pain, joint stiffness, and physical function issues over 84 days, along with improvements in quality of life and fatigue scores.
- The findings suggest that ParActin at both dosages is safe and effective for alleviating pain and improving life quality in people with mild to moderate knee osteoarthritis.]
Top posts
Most liked on X and BlueskyStudy of 100 participants / 26 weeks. Half received yeast beta-glucan and half received a placebo. Source: Graubaum et al., Food and Nutrition Sciences (2012) - A Double-Blind, Randomized, Placebo-Controlled Study on Beta-Glucan
A double-blind, randomized, placebo-controlled study of the safety and effects of CBN with and without CBD on sleep quality pubmed.ncbi.nlm.nih.gov/37796540/
Knee osteoarthritis pain? Try Andrographis paniculata. A new double‐blind, randomised, placebo‐controlled study has assessed the efficacy of Andrographis paniculata extract on pain reduction in subjects with #knee #osteoarthritis. # inflammation https://t.co/zL4lOPQyXV
https://t.co/fuiKwPnEO1
A double-blind, randomized, placebo-controlled study to assess the safety, antiviral activity and pharmacokinetics of GSK2336805 when given as monotherapy and in combination with peginterferon alfa-2a https://t.co/2stAJer4Re https://t.co/FM4IbJeqLT
All mentions
Research Review of Andrographis Paniculata as an Antiviral and Immune Booster
This educational video explores research on Andrographis paniculata, including its anti-inflammatory, antioxidant, antiviral properties, and potential benefits for respiratory conditions and autoimmune diseases.
ParActin Andrographis Extract for Inflammation and Osteoarthritis Relief
This video discusses the development of ParActin, a standardized Andrographis paniculata extract, focusing on its anti-inflammatory properties. It highlights recent studies demonstrating its effectiveness in reducing…
Study of 100 participants / 26 weeks. Half received yeast beta-glucan and half received a placebo. Source: Graubaum et al., Food and Nutrition Sciences (2012) - A Double-Blind, Randomized, Placebo-Controlled Study on Beta-Glucan
RT @EurekaMag: A double-blind, randomized, placebo-controlled study to assess the safety, antiviral activity and pharmacokinetics of GSK233…
RT @EurekaMag: A double-blind, randomized, placebo-controlled study to assess the safety, antiviral activity and pharmacokinetics of GSK233…
RT @EurekaMag: A double-blind, randomized, placebo-controlled study to assess the safety, antiviral activity and pharmacokinetics of GSK233…
RT @EurekaMag: A double-blind, randomized, placebo-controlled study to assess the safety, antiviral activity and pharmacokinetics of GSK233…
RT @EurekaMag: A double-blind, randomized, placebo-controlled study to assess the safety, antiviral activity and pharmacokinetics of GSK233…
RT @EurekaMag: A double-blind, randomized, placebo-controlled study to assess the safety, antiviral activity and pharmacokinetics of GSK233…
RT @EurekaMag: A double-blind, randomized, placebo-controlled study to assess the safety, antiviral activity and pharmacokinetics of GSK233…
RT @popline_org: A double-blind, randomized, placebo-controlled study to assess the safety, antiviral activity and pharmacokinetics of GSK2…
RT @popline_org: A double-blind, randomized, placebo-controlled study to assess the safety, antiviral activity and pharmacokinetics of GSK2…
RT @popline_org: A double-blind, randomized, placebo-controlled study to assess the safety, antiviral activity and pharmacokinetics of GSK2…
RT @popline_org: A double-blind, randomized, placebo-controlled study to assess the safety, antiviral activity and pharmacokinetics of GSK2…
A double-blind, randomized, placebo-controlled study to assess the safety, antiviral activity and pharmacokinetics of GSK2336805 when given as monotherapy and in combination with peginterferon alfa-2a https://t.co/z1rxEymiVf https://t.co/lnQqh2uJ6H
A double-blind, randomized, placebo-controlled study to assess the safety, antiviral activity and pharmacokinetics of GSK2336805 when given as monotherapy and in combination with peginterferon alfa-2a https://t.co/2stAJer4Re https://t.co/FM4IbJeqLT
A double-blind, randomized, placebo-controlled study of the safety and effects of CBN with and without CBD on sleep quality pubmed.ncbi.nlm.nih.gov/37796540/
L'andrographis paniculata semble avoir des propriétés anti-inflammatoires et est efficace contre l'arthrose. Utilisée pendant un essai qui a duré plusieurs mois, sans problèmes graves remontés. (300 à 600 mg de ParActin) https://t.co/vduYhiX9Nr ; https://t.co/3zEyUxbEws
https://t.co/fuiKwPnEO1
@NuclearYoshi @vonbateman Scepticism leads to septic choc :A double blind randomized placebo-controlled study to assess the stupidness of the patients New English journal of Moron
RT @DrMitchLow: Knee osteoarthritis pain? Try Andrographis paniculata. A new double‐blind, randomised, placebo‐controlled study has assesse…
Knee osteoarthritis pain? Try Andrographis paniculata. A new double‐blind, randomised, placebo‐controlled study has assessed the efficacy of Andrographis paniculata extract on pain reduction in subjects with #knee #osteoarthritis. # inflammation https://t.co/zL4lOPQyXV
K
DL
E
SA
A
SI
P
GN
S
SN
MF
D